RPS20P9

Across TCGA pan-cancer cohorts, RPS20P9 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPS20P9’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RPS20P9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS20P9 is over-expressed in tumor, although a few such as CHOL show the opposite, repressed pattern.

LUAD, LUSC, and ESCA are the cancer types where RPS20P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS20P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	IV	+0.324	.005	3	view →
LUSC	All	All	+0.084	.013	3	view →
ESCA	Male	All	+0.312	.022	2	view →
CHOL	All	All	−0.133	.001	2	view →
KIRC	All	II,III,IV	+0.047	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPS20P9–LUAD

Open the LUAD breakdown →